Based on the measurements of operating efficiency obtained from CbdMD's historical financial statements, cbdMD Inc may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. At present, CbdMD's Net Receivables is projected to increase significantly based on the last few years of reporting. The current year's Common Stock Total Equity is expected to grow to about 62.9 K, whereas Short and Long Term Debt Total is forecasted to decline to about 3.4 M. Key indicators impacting CbdMD's financial strength include:
Investors should never underestimate CbdMD's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor CbdMD's cash flow, debt, and profitability to make informed and accurate decisions about investing in cbdMD Inc.
Net Income
(21.68 Million)
CbdMD
Select Account or Indicator
Market Cap
Enterprise Value
Price To Sales Ratio
Dividend Yield
Ptb Ratio
Days Sales Outstanding
Book Value Per Share
Free Cash Flow Yield
Operating Cash Flow Per Share
Average Payables
Stock Based Compensation To Revenue
Capex To Depreciation
Pb Ratio
Ev To Sales
Free Cash Flow Per Share
Roic
Inventory Turnover
Net Income Per Share
Days Of Inventory On Hand
Payables Turnover
Sales General And Administrative To Revenue
Average Inventory
Research And Ddevelopement To Revenue
Capex To Revenue
Cash Per Share
Pocfratio
Interest Coverage
Payout Ratio
Capex To Operating Cash Flow
Pfcf Ratio
Days Payables Outstanding
Income Quality
Roe
Ev To Operating Cash Flow
Pe Ratio
Return On Tangible Assets
Ev To Free Cash Flow
Earnings Yield
Intangibles To Total Assets
Net Debt To E B I T D A
Current Ratio
Tangible Book Value Per Share
Receivables Turnover
Graham Number
Shareholders Equity Per Share
Debt To Equity
Capex Per Share
Graham Net Net
Average Receivables
Revenue Per Share
Interest Debt Per Share
Debt To Assets
Enterprise Value Over E B I T D A
Short Term Coverage Ratios
Price Earnings Ratio
Operating Cycle
Price Book Value Ratio
Price Earnings To Growth Ratio
Days Of Payables Outstanding
Dividend Payout Ratio
Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio
Pretax Profit Margin
Ebt Per Ebit
Operating Profit Margin
Effective Tax Rate
Company Equity Multiplier
Total Debt To Capitalization
Return On Capital Employed
Debt Equity Ratio
Ebit Per Revenue
Quick Ratio
Dividend Paid And Capex Coverage Ratio
Net Income Per E B T
Cash Ratio
Cash Conversion Cycle
Operating Cash Flow Sales Ratio
Days Of Inventory Outstanding
Days Of Sales Outstanding
Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios
Price To Book Ratio
Fixed Asset Turnover
Capital Expenditure Coverage Ratio
Price Cash Flow Ratio
Enterprise Value Multiple
Debt Ratio
Cash Flow To Debt Ratio
Price Sales Ratio
Return On Assets
Asset Turnover
Net Profit Margin
Gross Profit Margin
Price Fair Value
Return On Equity
Sale Purchase Of Stock
Change In Cash
Total Cashflows From Investing Activities
Other Cashflows From Financing Activities
Depreciation
Capital Expenditures
Total Cash From Operating Activities
Net Income
Total Cash From Financing Activities
End Period Cash Flow
Change To Inventory
Investments
Stock Based Compensation
Free Cash Flow
Change In Working Capital
Begin Period Cash Flow
Other Non Cash Items
Change To Account Receivables
Net Borrowings
Dividends Paid
Change To Operating Activities
Issuance Of Capital Stock
Change To Netincome
Change To Liabilities
Total Assets
Short Long Term Debt Total
Other Current Liab
Total Current Liabilities
Total Stockholder Equity
Property Plant And Equipment Net
Net Debt
Retained Earnings
Accounts Payable
Cash
Non Current Assets Total
Cash And Short Term Investments
Net Receivables
Common Stock Total Equity
Liabilities And Stockholders Equity
Non Current Liabilities Total
Capital Surpluse
Inventory
Other Current Assets
Other Stockholder Equity
Total Liab
Property Plant And Equipment Gross
Total Current Assets
Accumulated Other Comprehensive Income
Short Term Debt
Intangible Assets
Common Stock
Property Plant Equipment
Non Currrent Assets Other
Common Stock Shares Outstanding
Short Long Term Debt
Current Deferred Revenue
Long Term Debt
Short Term Investments
Net Invested Capital
Net Working Capital
Other Liab
Net Tangible Assets
Other Assets
Capital Stock
Non Current Liabilities Other
Capital Lease Obligations
Long Term Investments
Tax Provision
Interest Income
Interest Expense
Total Revenue
Gross Profit
Operating Income
Cost Of Revenue
Income Before Tax
Net Income Applicable To Common Shares
Income Tax Expense
Net Interest Income
Depreciation And Amortization
Other Operating Expenses
Net Income From Continuing Ops
Ebit
Ebitda
Total Operating Expenses
Total Other Income Expense Net
Reconciled Depreciation
Discontinued Operations
Selling General Administrative
Minority Interest
Selling And Marketing Expenses
Research Development
Probability Of Bankruptcy
Understanding current and past CbdMD Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of CbdMD's financial statements are interrelated, with each one affecting the others. For example, an increase in CbdMD's assets may result in an increase in income on the income statement.
Please note, the presentation of CbdMD's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, CbdMD's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of CbdMD's management manipulating its earnings.
CbdMD Stock Summary
CbdMD competes with Trulieve Cannabis, Curaleaf Holdings, Green Thumb, China Pharma, and China SXT. cbdMD, Inc. produces and distributes various cannabidiol products. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. was incorporated in 2015 and is headquartered in Charlotte, North Carolina. CbdMD operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on AMEX Exchange. It employs 105 people.
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
Comparative valuation techniques use various fundamental indicators to help in determining CbdMD's current stock value. Our valuation model uses many indicators to compare CbdMD value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CbdMD competition to find correlations between indicators driving CbdMD's intrinsic value. More Info.
cbdMD Inc is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, CbdMD's Return On Equity is projected to increase based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value CbdMD by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
cbdMD Inc Systematic Risk
CbdMD's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. CbdMD volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on cbdMD Inc correlated with the market. If Beta is less than 0 CbdMD generally moves in the opposite direction as compared to the market. If CbdMD Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one cbdMD Inc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of CbdMD is generally in the same direction as the market. If Beta > 1 CbdMD moves generally in the same direction as, but more than the movement of the benchmark.
CbdMD Thematic Clasifications
cbdMD Inc is part of Consumer Goods investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. USA Equities from Consumer Goods industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions
This theme covers USA Equities from Consumer Goods industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions. Get More Thematic Ideas
Today, most investors in CbdMD Stock are looking for potential investment opportunities by analyzing not only static indicators but also various CbdMD's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of CbdMD growth as a starting point in their analysis.
Price Earnings To Growth Ratio
0.001303
At present, CbdMD's Price Earnings To Growth Ratio is projected to slightly decrease based on the last few years of reporting.
CbdMD November 30, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of CbdMD help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of cbdMD Inc. We use our internally-developed statistical techniques to arrive at the intrinsic value of cbdMD Inc based on widely used predictive technical indicators. In general, we focus on analyzing CbdMD Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build CbdMD's daily price indicators and compare them against related drivers.
When running CbdMD's price analysis, check to measure CbdMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CbdMD is operating at the current time. Most of CbdMD's value examination focuses on studying past and present price action to predict the probability of CbdMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CbdMD's price. Additionally, you may evaluate how the addition of CbdMD to your portfolios can decrease your overall portfolio volatility.